DSG Partners Asia, which targets early-stage consumer opportunities in India and Southeast Asia, has closed its second fund at the hard cap of $50 million. Everstone Capital bought a 50% stake in the GP last year.
DSG reached its target of $40 million in April, with half the contributions coming from Fund I investors – primarily high net worth individuals – and half from four institutional players. They are...
Motilal Oswal Private Equity (MOPE) and healthcare-focused GP Invascent Capital have invested in Indian pharmaceutical developer Symbiotec Pharmalab, providing an exit for Actis Capital.
The transformation of Manuka Health from loosely run family affair into professional segment leader helped organize a cottage industry into big business
A selection of the key fundraising, investment and exit events - presented in chronological order - from the past 12 months
Fuyoukache, a Chinese online truck logistics platform, has raised $170 million in a Series D round led by a Bank of China investment unit and Matrix Partners China. Prospect Avenue Capital also participated.